Product features

Assays based on the indirect ELISA method, where antibodies present in the sample react with antigens bound to the surface of the wells. Products identified as CAPTURE use µ-Capture technology for IgM detection.

  • Direct in-well sample dilution and equivalent processing of samples and controls to help compensate pipetting variability.
  • Colour-coded, ready-to-use liquid reagents and individual break-apart wells.
  • Suitable for manual processing and compatible with automated ELISA systems.
Kit ELISA

PRODUCTS

RUBELLA ELISA IgG

CE0318
Indirect immunoenzyme assay to test IgG antibodies against rubella virus in human serum/plasma.

Analytes: Rubella virus

Reference G1026
Pack size 96 tests

RUBELLA ELISA IgM CAPTURE

CE0123 IVDR
Capture immunoenzyme assay to test IgM antibodies against rubella virus in human serum/plasma.

Analytes: Rubella virus

Reference M1026
Pack size 96 tests

MORE RESOURCES

Virus/Bacterias
RELATED VIRUSES/BACTERIA

Related germs and organisms categorized for this product line.

Rubella virus
Flyers
FLYERS

Downloadable PDF materials, brochures, and technical documents.

ELISA Brochure
ELISA Brochure
Immunology Catalogue
Immunology Catalogue
Blog
BLOG

The latest insights, news, and research articles from our scientific team.

Measles in the Americas in 2026: strengthening laboratory diagnosis amid rising cases
21 October 2026

Measles in the Americas in 2026: strengthening laboratory diagnosis amid rising cases

Measles is once again a major public health concern across the Americas.After years of progress towards elimination, measles has made a significant co...

H. pylori stool antigen testing: when the test works, but the workflow no longer does
21 September 2026

H. pylori stool antigen testing: when the test works, but the workflow no longer does

Helicobacter pylori stool antigen testing is an established non-invasive approach for detecting active H. pylori infection. Validated monoclonal stool...

Polymicrobial Vaginal Infections: why third-party controls matter in molecular testing
10 August 2026

Polymicrobial Vaginal Infections: why third-party controls matter in molecular testing

Understanding the complexity of vaginal infectionsVaginal infections are among the most frequent reasons for gynecological consultation, but their dia...

Bibliography
BIBLIOGRAPHY

Scientific bibliography and references related to this product.

Fiestas Solórzano V, Gonzáles Noriega M, Fiestas F, Cabezudo E, Suárez M, Suárez V. Evaluation of the seroprotection against measles, rubella and hepatitis B in children under 5 years of age in Peru, 2011. Rev Peru Med Exp Salud Publica. 2012;29(4):437–43
Ghafoori F, Mokhtari-Azad T, Foroushani AR, Farahmand M, Shadab A, Salimi V. Assessing seropositivity of MMR antibodies in individuals aged 2–22: evaluating routine vaccination effectiveness after the 2003 mass campaign—a study from Iran’s National Measle
Guerrero-Fernández MM, Serrano-Álvarez C, Foronda-Bengoa J, Barrero-Hernández FJ, Sorlózano-Puerto A. Intrathecal synthesis of Epstein-Barr virus antibodies 15 years before onset of multiple sclerosis. Mult Scler. 2026 Apr;32(4):444-447
Rahmanian E, Mogharab F, Mogharab V. A Review of Anti-Measles and Anti-Rubella Antibodies in 15 - 25 Year Old Women in Jahrom City In 2011. World Family Medicine Journal/Middle East Journal of Family Medicine. 2017 Nov;15(9):128–34.
Saffar H, Mousavi SJ, Saffar H, et al. Seroimmunity status to measles-mumps-rubella-varicella-pertussis-diphtheria-tetanus among students accepted to Mazandaran University of Medical Science, Sari, North of Iran, 2018-2019: planning for preventive method.
See more